Bench to Bedside: From the Science to the Practice of Addiction Medicine

Similar documents
Gambling Disorder as a Behavioral Addiction

Motivational Interviewing for Clinical Practice

Fundaments of Addiction Medicine. Addiction Medicine Express All of Addiction Medicine in 60 Slides and 60 minutes

Buprenorphine and MAT 101

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Medication-Assisted Treatment (MAT) Overview

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

Confronting the Opioid Epidemic: Suboxone in Primary Care

Vivitrol/Suboxone. Comparison Study Summary

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

Medication Assisted Treatment of Substance Use Disorders

Opioid Use Disorder Treatment Initiation in Diverse Settings

It s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs

Mass General s Substance Use Disorder Initiative

V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS

The role of behavioral interventions in buprenorphine treatment of opioid use disorders

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

THE STATE OF MEDICINE IN ADDICTION RECOVERY

Vivitrol Vs. Suboxone

Opioid Overdose Epidemic A Crises and Opportunity

Noel Schenk MD. Davis Behavioral Health

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.

Best Practice Workgroup Considerations. New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011

GOALS AND OBJECTIVES

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Making Referrals. Welcome to the Recovery U module on making referrals.

Listen & Hear 4Lo

Close to Home A Recovery Brief WNC Recovery Recovery Ministries of the Episcopal Church

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Opioid Dependence 101 and Medication Assisted Treatment

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

BASIC VOLUME. Elements of Drug Dependence Treatment

Buprenorphine as a Treatment Option for Opioid Use Disorder

Medication Supported Recovery- A Review of Evidence-Based Practice

Enhanced Substance Abuse Management in Higher Risk Populations

STIMULANTS. 1980s: Cocaine. Outline. General Roadmap

What are Substance Use Disorders?

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Opioid Use Disorders &Medication Treatment

Can 12 Step and Medications for Substance Use Disorders Co-Exist?

Opiate Use Disorder and Opiate Overdose

LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond

Opioid Use in Youth. Amy Yule M.D. March 2,

Advancing Addiction Science to Address the Opioid Crisis

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Buprenorphine pharmacology

Drug Addiction Is a Disease So What Do We Do about It?

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

SUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Treatment Approaches for Drug Addiction

MAT 101: TREATMENT OF OPIOID USE DISORDER

The Opiate Crisis. Presented by Dr. Anahi Ortiz Franklin County Coroner. October 24, 2018

Opiate Addiction: Treatment Perspectives

7/7/2016 Journal of the American Medical Association,

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus

Discover the Hope: Opiate Treatment and Recovery

Opioid Epidemic as it Relates to Counties

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Navigating the. Addiction. A Four-Letter Word!!! What is Addiction? Definition of Addiction: Definition of Addiction: (cont)

IntNSA Webinar Series

Division of Mental Health and Addiction Services

Safe Practices and Action Items

Opioids and Opioid Addiction: Practical Management Approaches

LA County, Medications for Addiction Treatment, and the Substance Use Care Continuum

HOUSE Calls. Addiction Medicine. Winter Published by the Alachua County Medical Society

The Opioid Crisis: What Can Physicians Do About It?

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Striking a Balance: a provider perspective.

Overview of Opioid Use Disorder

11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

MAT in the Corrections Setting

Medication-Assisted Treatment (MAT) for Opioid Use Disorders

Medication Assisted Treatment

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Appendix A. Socio-demographic Characteristics of Survey Respondents Compared to Current Population Survey (2013) Data

LGBT PERSPECTIVES IN ADDICTION MEDICINE

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Neuroscience of Addiction

5/30/ New England Summer School Lindy S. Keller, M.S., MLADC - NH Bureau of Drug & Alcohol Services. Objectives

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic. What should we do with this case? Heroin Addiction History

Transcription:

Bench to Bedside: From the Science to the Practice of Addiction Medicine Petros Levounis, MD, MA Chair, Department of Psychiatry Rutgers New Jersey Medical School ADDICTION MEDICINE ACADEMY Clearwater Beach, Florida March 26, 2015

Outline 1. The Neurobiology of Addiction 2. Psychosocial Treatments 3. Pharmacological Treatments 4. Conclusions 2

1 Neurobiology of Addiction 3

~ 2000 4

The Fundamental Model Biological Psychological Addiction Social Use Brain Switch 5 Olsen and Levounis, Sober Siblings, 2008.

2015 6

Three Novel Areas 1. Continuum of Illness 2. Motivational Circuitry 3. Antireward Pathways 7

Reward Systems GAME 1? A. A sure gain of $250. B. 25% chance to gain $1,000, 75% chance to gain nothing. Adapted from: Tversky and Kahneman, Science, 1981. 8

Reward Systems GAME 1? A. A sure gain of $250. 84% B. 25% chance to gain $1,000, 16% 75% chance to gain nothing. Adapted from: Tversky and Kahneman, Science, 1981. 9

Antireward Systems GAME 2? A. A sure loss of $750. B. 25% chance to lose nothing, 75% chance to lose $1,000. Adapted from: Tversky and Kahneman, Science, 1981. 10

Antireward Systems GAME 2? A. A sure loss of $750. 13% B. 25% chance to lose nothing, 87% 75% chance to lose $1,000. Adapted from: Tversky and Kahneman, Science, 1981. 11

MATHEMATICS GAME 1 25% + 750 25% - 250 25% - 250 25% - 250 GAME 2 25% + 750 25% - 250 25% - 250 25% - 250 12

HUMAN NATURE People avoid risks to ensure gains (even small gains). People take risks (even big risks) to avoid definite losses. Psychology trumps probability. 13

2 Psychosocial Treatments 14

1 st Wave: Psychoanalysis 1. Psychoanalysis works for all treatable mental illness. 2. Psychoanalysis does not work for addiction. 3. Therefore, addiction cannot be treated. 15

2 nd Wave: Boot Camps The prototype, Synanon, was founded in California in 1958 to address heroin addiction. The goal was to: Ø break down defenses, Ø bust through denial, and Ø reshape the addict s personality. 16

The Frying Pan 17 Volkow et al, J Neuroscience, 2001

3 rd : The Kitchen Sink Approach 1. Mutual Help Groups (12-step) 2. Cognitive Behavioral Therapy 3. Family Therapy 4. Primary Care Services 5. Mental Health Services 6. Aftercare Nunes, Selzer, Levounis, Davies, Substance Dependence and Co-Occurring Psychiatric Disorders, 2010. 18

Mutual Help 19

Attitudes and Perceptions MEDICAL STAFF 1. Housing 2. Gov t Services 3. Medical Services 4. Outpatient Tx 5. Job 6. Community 7. Trusting People 8. Inner peace 9. God 10. Spirituality 11. AA PATIENTS 1. Inner peace 2. God 3. Medical Services 4. AA 5. Housing 6. Spirituality 7. Outpatient Tx 8. Community 9. Gov t Services 10. Trusting People 11. Job What Medicine Thinks Patients Think 1. Housing 2. Outpatient Tx 3. Medical Services 4. Job 5. Trusting People 6. AA 7. Inner Peace 8. Community 9. Gov t Services 10. Spirituality 11. God 20 Goldfarb, Am J Drug Alcohol Abuse, 1996.

4 th : Motivational Interviewing (MI) Levounis and Arnaout, Handbook of Motivation and Change: A Practical Guide for Clinicians, 2010. Graphic by Lukas Hassel. 21

5 th : Mentalization Between stimulus and response there is a space. In that space is our power to choose our response. In our response lie our growth and our freedom. Viktor E. Frankl Frankl V, Man s Search for Meaning, 1959. 22

23

And Back to Psychodynamics % reporting any substance use disorders 40 30 20 10 0 Only same-sex Mostly same-sex Equally both sexes Mostly other sex Only other sex * 11.4 *** 24.2 25 * 9.6 *** 13.2 Ref 5.6 17.7 18.5 15.7 12.2 Women Men *p<0.05, ***p<.001 based on logistic regression analysis adjusted for race, age, educational level, personal income, employment status, relationship status, health insurance status, geographic location, MSA, age at alcohol onset, and family history of AOD problems. Reference group was heterosexual group. 24 Courtesy of Sean McCabe, PhD.

3 Pharmacological Treatments 25

The Prescription Opioids Epidemic: The Root of the Disaster 26 Porter and Jick, N Engl J Med, January 10, 1980.

Chronic Non-Cancer Pain 27

Admissions: 1999 Primary non-heroin opioid admission rates (per 100,000) 28

Admissions: 2001 Primary non-heroin opioid admission rates (per 100,000) 29

Admissions: 2003 Primary non-heroin opioid admission rates (per 100,000) 30

Admissions: 2005 Primary non-heroin opioid admission rates (per 100,000) 31

Admissions: 2007 Primary non-heroin opioid admission rates (per 100,000) 32

Admissions: 2009 Primary non-heroin opioid admission rates (per 100,000) 33

Unintentional Drug Poisoning Deaths United States: 1970 2007 10 9 8 Death rate per 100,000 7 6 5 4 3 2 Heroin Cocaine 1 0 Year '70 '72 '74 '76 '78 '80 '82 '84 '86 '88 '90 '92 '94 '96 '98 '00 '02 '04 '06 National Vital Statistics System, http://wonder.cdc.gov. 34

Unintentional Drug Poisoning Deaths United States: 1999 2011 Alcorn, The Lancet, June 5, 2014. 35

Addiction Strategies Ø Agonists: Methadone Nicotine Replacement Ø Partial Agonists: Buprenorphine Varenicline Ø Antagonists: Naltrexone Levounis and Herron, The Addiction Casebook, 2014. 36

The Ceiling Effect 100 % Efficacy 90 80 70 60 50 40 30 20 10 0 Full Agonist (Methadone) Partial Agonist (Buprenorphine) Antagonist (Naloxone) -10-9 -8-7 -6-5 -4 Log Dose of Opioid Adapted from: Renner and Levounis, Office-Based Buprenorphine Treatment of Opioid Dependence, 2011. 37

4 Conclusions 38

1. Addiction hijacks the pleasure/reward and anti-reward pathways of the brain, as well as the person s internal motivation. 2. Cognitive Behavior Therapy, mutual help groups, and Motivational Interviewing revolutionized addiction treatment. 3. In 2015, buprenorphine is the first line treatment of opioid use disorder. 39

Thank you NJMS.Rutgers.edu/Psychiatry 40